4-HYDROXYMETHYL-4-METHYL-1-PHENYL-3-PYRAZOLIDONE, 95%, 500g

N-(5-acetyl-1,3-thiazol-2-yl)-2,2-dimethylpropanamide, 95.0%, 5g

Chloro[(1,3-dimesitylimidazol-2-ylidene)(N,N-dimethylbenzylamine)palladium(II)]>98.0%(T)1g

Vasos Griffin, 5000 ml, 1 Pieza

(4-Bromo-5-methylpyridin-2-yl)methanol, 97%, 100mg

[4-(4-Methoxycarbonylphenyl)phenyl]boronic acid, 98%, 25g

3,4-Difluorothiophenol, 95.0%, 25g

(5-Bromopyrimidin-2-yl)acetic acid ethyl ester, 98.0%, 10g

(1R,2R)-2-(1,3-dioxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl)cyclohexane-1-carboxylic acid, 95+%, 10mg

N-AMINOBENZENECARBOTHIOAMIDE, 95%, 50mg

3,4-Dichloro-n-propylbenzene-1-sulfonamide, 95%, 10g

2,5-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiophene, 97.0%, 25g

Guardcolumnas HPLC (analíticas) NUCLEODUR® NH2-RP 3 µm, 4x3 mm, 3 Pieza(s)